bethanechol has been researched along with Esophageal Diseases in 7 studies
Bethanechol: A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM.
bethanechol : The carbamic acid ester of 2-methylcholine. A slowly hydrolysed muscarinic agonist with no nicotinic effects, it is used as its chloride salt to increase smooth muscle tone, as in the gastrointestinal tract following abdominal surgery, treatment of gastro-oesophageal reflux disease, and as an alternative to catheterisation in the treatment of non-obstructive urinary retention.
Esophageal Diseases: Pathological processes in the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To determine if bethanechol stimulation would increase the diagnostic yield, we examined 87 patients with chest pain but no gastroesophageal reflux, 47 patients with gastroesophageal reflux but no chest pain, and 20 normal subjects." | 7.67 | Bethanechol increases the diagnostic yield in patients with esophageal chest pain. ( Huber, T; Nostrant, TT; Sams, J, 1986) |
| " To determine if bethanechol stimulation would increase the diagnostic yield, we examined 87 patients with chest pain but no gastroesophageal reflux, 47 patients with gastroesophageal reflux but no chest pain, and 20 normal subjects." | 3.67 | Bethanechol increases the diagnostic yield in patients with esophageal chest pain. ( Huber, T; Nostrant, TT; Sams, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mellow, MH | 1 |
| Anselmino, M | 1 |
| Clark, GW | 1 |
| Hinder, RA | 1 |
| Fan, YP | 1 |
| Chakder, S | 1 |
| Gao, F | 1 |
| Rattan, S | 1 |
| Cole, MJ | 1 |
| Paterson, WG | 1 |
| Beck, IT | 1 |
| DaCosta, LR | 1 |
| Spechler, SJ | 1 |
| Goyal, RK | 1 |
| Nostrant, TT | 1 |
| Sams, J | 1 |
| Huber, T | 1 |
| Humphries, TJ | 1 |
2 reviews available for bethanechol and Esophageal Diseases
| Article | Year |
|---|---|
Esophageal chest pain: state of the art.
Topics: Bethanechol; Bethanechol Compounds; Calcium Channel Blockers; Chest Pain; Diagnosis, Differential; E | 1993 |
Barrett's esophagus.
Topics: Adenocarcinoma; Antacids; Barrett Esophagus; Bethanechol; Bethanechol Compounds; Cimetidine; Epithel | 1986 |
5 other studies available for bethanechol and Esophageal Diseases
| Article | Year |
|---|---|
Effect of isosorbide and hydralazine in painful primary esophageal motility disorders.
Topics: Adult; Aged; Bethanechol; Bethanechol Compounds; Deglutition Disorders; Esophageal Diseases; Esophag | 1982 |
Inducible and neuronal nitric oxide synthase involvement in lipopolysaccharide-induced sphincteric dysfunction.
Topics: Anal Canal; Animals; Atrial Natriuretic Factor; Bethanechol; Electric Stimulation; Enteric Nervous S | 2001 |
The effect of acid and bethanechol stimulation in patients with symptomatic hypertensive peristaltic (nutcracker) esophagus. Evidence that this disorder may be a precursor of diffuse esophageal spasm.
Topics: Adult; Aged; Bethanechol; Bethanechol Compounds; Esophageal Diseases; Humans; Hydrochloric Acid; Man | 1986 |
Bethanechol increases the diagnostic yield in patients with esophageal chest pain.
Topics: Adult; Aged; Bethanechol; Bethanechol Compounds; Esophageal Diseases; Esophagus; Female; Gastroesoph | 1986 |
Effects of long-term medical treatment with cimetidine and bethanechol in patients with esophagitis and Barrett's esophagus.
Topics: Adult; Barrett Esophagus; Bethanechol; Bethanechol Compounds; Cimetidine; Esophageal Diseases; Esoph | 1987 |